PHAT

Phathom Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 2/10
Phathom Pharmaceuticals sales and earnings growth
PHAT Growth
Good
  • Revenue Y/Y↑ 121.20%
  • EPS Y/Y↑ 59.54%
  • FCF Y/Y↑ 65.43%
Phathom Pharmaceuticals gross and profit margin trends
PHAT Profitability
Good
  • Gross margin ↑ 84.90%
  • EPS margin↓ -76.80%
  • ROIC 5Y↓ -51.38%
Phathom Pharmaceuticals net debt vs free cash flow
PHAT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 3.4
  • Interest coverage↓ -1.4

Phathom Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks